Bide Pharmatech Co (SHSE:688073) Total Liabilities : ¥337 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bide Pharmatech Co Total Liabilities?

Bide Pharmatech Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥337 Mil.

Bide Pharmatech Co's quarterly Total Liabilities declined from Sep. 2023 (¥331.92 Mil) to Dec. 2023 (¥325.49 Mil) but then increased from Dec. 2023 (¥325.49 Mil) to Mar. 2024 (¥336.68 Mil).

Bide Pharmatech Co's annual Total Liabilities increased from Dec. 2021 (¥277.27 Mil) to Dec. 2022 (¥283.05 Mil) and increased from Dec. 2022 (¥283.05 Mil) to Dec. 2023 (¥325.49 Mil).

Bide Pharmatech Co Total Liabilities Historical Data

The historical data trend for Bide Pharmatech Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bide Pharmatech Co Total Liabilities Chart

Bide Pharmatech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

129.33

167.64

277.27

283.05

325.49

Bide Pharmatech Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial											317.44	343.88	331.92	325.49	336.68

Bide Pharmatech Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bide Pharmatech Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	274.97	+	(41.186	+	9.33
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	325

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2415.028	-	2089.542
	=	325

Bide Pharmatech Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	296.518	+	(32.041	+	8.12
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	337

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	2381.92	-	2045.24
	=	337

Bide Pharmatech Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Bide Pharmatech Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bide Pharmatech Co (SHSE:688073) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bide Pharmatech Co Ltd (SHSE:688073) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 128, Xiangyin Road, Room 101, Block A, Building 11, Yangpu District, Shanghai, CHN, 200433

Website

https://www.bidepharmatech.com

Bide Pharmatech Co Ltd is engaged in the research and development, design, production and sales of drug molecular building blocks.

Executives

Dai Lan

Director

Bide Pharmatech Co (SHSE:688073) Headlines

No Headlines